SCHEMBL26017367

SCHEMBL26017367

CC(C)(C)c1ccc(-c2nc3ccccc3n2C2CCCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ HPGD P15428 1/20 0.53
▸ XBP1 P17861 1/20 0.53
▸ ALOX12 P18054 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ CYP11B2 P19099 2/20 0.52
▸ RPS6KB1 P23443 4/20 0.51
▸ ROCK1 Q13464 4/20 0.51
▸ PRKACA P17612 3/20 0.51
▸ GSK3B P49841 3/20 0.51
▸ TP53 P04637 3/20 0.49
▸ OPRM1 P35372 4/20 0.47
▸ OPRL1 P41146 4/20 0.47
▸ OPRD1 P41143 2/20 0.47
▸ OPRK1 P41145 1/20 0.47
▸ CYP11B1 P15538 1/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC8 Q9BY41 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26017426 0.99 SMN1; SMN2 (0.52) LMNASMN1; SMN2ALDH1A1HPGDXBP1
SCHEMBL28236159 0.83 CYP11B2 (0.63) CYP11B2RPS6KB1ROCK1PRKACAGSK3B
SCHEMBL31267414 0.81 RPS6KB1 (0.62) LMNASMN1; SMN2ALDH1A1HPGDCYP11B2
SCHEMBL14382679 0.79 L3MBTL1 (0.65) LMNASMN1; SMN2ALDH1A1HPGDXBP1
SCHEMBL26017755 0.76 ESR2 (0.60) LMNAALDH1A1NPSR1TP53HDAC6
SCHEMBL31267525 0.76 ALDH1A1 (0.60) LMNASMN1; SMN2ALDH1A1CYP11B2RPS6KB1
SCHEMBL21705123 0.76 ALDH1A1 (0.67) LMNASMN1; SMN2ALDH1A1HPGDNPSR1
SCHEMBL31261250 0.76 ALDH1A1 (0.67) LMNASMN1; SMN2ALDH1A1HPGDNPSR1
SCHEMBL16386807 0.76 SMN1; SMN2 (0.55) LMNASMN1; SMN2ALDH1A1HPGDXBP1
SCHEMBL3448194 0.75 GAA (0.61) LMNASMN1; SMN2ALDH1A1NPSR1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713333-B2 Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-08-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713333-B2 Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound ORC3, LAGE3, ORMDL3 LMNA 3940/4885SMN1; SMN2 4036/4885ALDH1A1 809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback